72122-62-4
72122-62-4 结构式
基本信息
婴儿猝死综合征/酪啡肽Β/-CASOMORPHIN抗体
β-Casomorphin-7
BETA CASOMORPHIN
BETA-CASOMORPHIN-7
β-Casomorphin 7【ox】
β-Casomorphin-7【ox】
β-Casomorphin, bovine
β-Casomorphin(cattle)
b-Casomorphin (bovine)
BETA-CASOMORPHIN (BOVINE)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/04/30 | HY-P0179 | Β-酪啡肽-7 β-Casomorphin, bovine | 72122-62-4 | 5mg | 800元 |
| 2024/04/30 | HY-P0179 | Β-酪啡肽-7 β-Casomorphin, bovine | 72122-62-4 | 10mg | 1400元 |
| 2024/04/30 | HY-P0179 | Β-酪啡肽-7 β-Casomorphin, bovine | 72122-62-4 | 25 mg | 2900元 |
常见问题列表
IC50: 14 μM (Opioid receptor)
β-Casomorphin, bovine (0.1 μM; 30 minutes-24 hours) stimulates the secretion of mucin in DHE Cells after 8 h of treatment.
β-Casomorphin, bovine (0.1 μM; 24 hours) induces an increase in rMuc2 and rMuc3 mRNA levels.
β-Casomorphin, bovine do not modify the expression of rMuc1, rMuc4, and rMuc5AC.
β-Casomorphin, bovine (0.1 μM; 24 hours) stimulates MUC5AC expression and mucin Secretion in HT29-MTX Cells (human).
β-Casomorphin, bovine (7.5×10
−6
mol/day/kg ; i.g.; for 30 days) increases plasma insulin and decreased plasma glucagon of diabetic rats.
β-Casomorphin, bovine (7.5×10
−6
mol/day/kg ; i.g.; for 30 days) alters the changes of SOD, GPx, T-AOC, MDA and H2O2 in the kidney of diabetic rats.
β-Casomorphin, bovine (7.5×10
−6
mol/day/kg ; i.g.; for 30 days) reduces MDA (significantly) and H2O2 (non-significantly) level in the kidney compared to the diabetic rats.
β-Casomorphin, bovine (7.5×10
−6
mol/day/kg ; i.g.; for 30 days) alleviates high glucose-induced decreasement in SOD and GPx activity, increasement in MDA contents in the NRK-52E cells.
| Animal Model: | Male Sprague-Dawley (SD) rats (200 g±10 g) |
| Dosage: | 7.5×10 −6 mol/day/kg |
| Administration: | Oral gavage; for 30 days |
| Result: | Increased plasma insulin and decreased plasma glucagon of diabetic rats. |